Identification of Hypoxia and Mitochondrial-related Gene Signature and Prediction of Prognostic Model in Lung Adenocarcinoma
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study developed a 16-gene prognostic model for lung adenocarcinoma (LUAD) by analyzing hypoxia and mitochondrial gene expression. This model accurately predicts patient outcomes and may guide treatment decisions.
Area Of Science
- Oncology
- Bioinformatics
- Molecular Biology
Background
- Hypoxia is linked to tumor development, primarily affecting mitochondria.
- Mitochondrial dysfunction is implicated in lung adenocarcinoma (LUAD) progression.
- Investigating hypoxia-related mitochondrial genes offers potential prognostic insights for LUAD.
Purpose Of The Study
- To determine the prognostic value of hypoxia and mitochondrial scores in lung adenocarcinoma (LUAD).
- To establish a robust prognostic model for LUAD based on identified gene signatures.
- To validate the model's accuracy and clinical utility for patient stratification and treatment guidance.
Main Methods
- Computed hypoxia and mitochondrial scores using single-sample Gene Set Enrichment Analysis (ssGSEA).
- Identified differentially expressed genes and utilized weighted gene co-expression network analysis (WGCNA).
- Developed a prognostic model with 16 genes via least absolute shrinkage and selection operator (LASSO) Cox regression and validated it using independent datasets and nomograms.
Main Results
- Identified 318 differentially expressed genes associated with hypoxia and mitochondrial scores.
- A 16-gene prognostic model demonstrated high predictive accuracy for LUAD prognosis.
- Risk scores correlated with tumor microenvironment components and predicted improved chemotherapy efficacy.
Conclusions
- A 16-gene prognostic model and nomogram were successfully established for LUAD.
- This model accurately predicts LUAD patient prognosis and aids in clinical decision-making.
- Findings support the use of this model for personalized treatment strategies in LUAD.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.